Definium Therapeutics Inc. Common Shares (DFTX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Definium Therapeutics Inc. Common Shares (DFTX) is Neutral.

The composite score behind that read is -0.13, weighing +0.25 of bullish evidence against -0.26 bearish.

Definium Therapeutics Inc. Common Shares last closed at $36.23, -3.13% on the session.

Against the IVW growth benchmark the position is -4.05% over the forecast window.

The read is built from 13 underlying insights — 3 bullish and 10 bearish.

Agreement across those insights is 77%.

Definium Therapeutics Inc. Common Shares has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Definium Therapeutics Inc. Common Shares in the 13th percentile on return on equity, where 100 is best.

Definium Therapeutics Inc. Common Shares is classified under Health Care / Pharmaceuticals, with a market capitalisation of $5.03B.

StockMap tracks Definium Therapeutics Inc. Common Shares as the 23rd largest of the 128 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 54 Moderate Underperform, 53 Neutral, 15 Strong Underperform and 6 Moderate Outperform.

On that composite Definium Therapeutics Inc. Common Shares ranks 46th of 128 in the group, against a group median of -0.24.